Skip to main content
. 2020 Oct 14;9(10):e1193. doi: 10.1002/cti2.1193

Figure 1.

Figure 1

Overview of the CMV antibody levels of all participants during time. (a) Study design. Participants (n = 135 men, n = 133 women) donated blood 6 times in ~ 27 years. In 2016–2017, an extra sample was taken for extensive phenotyping of leucocyte subsets. (b) CMV antibody levels were measured every 5 years and presented per age category at study endpoint separately for men and woman. Green lines show the antibody trajectories of CMV‐ participants, purple lines those of LT CMV+ participants, and the bold blue lines those of the participants that seroconverted during follow‐up (ST CMV+ participants). Dotted horizontal line shows the cut‐off value for seropositivity.